Based on ACR rules, allopurinol is strongly advisable as a primary-line urate-reducing medication. Genetic screening is suggested (for just a variant called HLA B*5801) previous to commencing allopurinol because the carriers of this gene are at an elevated possibility of a critical allergic response.• Allopurinol is the preferred urate-decreasing